
Healthy or diseased?
The ratio between the concentrations of metabolites may give the answer to the question. Researchers at the Helmholtz Zentrum in Munich demonstrated the proof of principle. They identified diabetic or healthy mice by biomarkers they analyzed only by bioinformatics. Metabolomics might permit a promising tool for pre-clinical investigation of effects and side effects of new drugs, they say.
















